Related Experiment Videos
Methylmethacrylate is a mutagen for Salmonella typhimurium
The Journal of Bone and Joint Surgery. American Volume
|December 1, 1979
Summary
Methylmethacrylate (MMA) shows mutagenic potential in Salmonella typhimurium, particularly after metabolic activation. Its intermediate metabolite is identified as the mutagenic agent, highlighting potential long-term health risks.
Area of Science:
- Toxicology
- Mutagenesis Research
- Chemical Safety
Background:
- Long-term effects of monomeric methylmethacrylate (MMA) exposure are not well-established.
- Assessing the toxicological profile of MMA is crucial for occupational and environmental safety.
Purpose of the Study:
- To evaluate the toxicity and mutagenicity of methylmethacrylate (MMA) in bacterial systems.
- To investigate the role of metabolic activation in MMA-induced mutagenesis.
Main Methods:
- Bacterial toxicity and mutagenicity assays using Salmonella typhimurium.
- Incubation of MMA with a rat-liver enzyme metabolizing system to assess metabolic activation.
Main Results:
- Methylmethacrylate (MMA) demonstrated 28% of the mutagenic activity of dimethylnitrosamine at 34 millimolar.
- MMA alone exhibited toxicity, but metabolic activation induced significant mutagenesis.
- An intermediate metabolite of MMA was identified as the mutagenic agent.
Conclusions:
- The intermediate metabolite of methylmethacrylate (MMA) is mutagenic to Salmonella typhimurium.
- Metabolic activation is a key factor in MMA-induced mutagenicity.
- Further research is needed to establish the long-term health implications of MMA exposure.